As previously mentioned, PROTAC DT2216 is a specific BCL‐XL protein degrader, with high cytotoxicity against MOLT‐4 T‐ALL cells in vitro, without relevant platelet toxicity.99 Here, BCL2L1 is linked to acute lymphoblastic leukemia.